Director Shareholding

GlaxoSmithKline PLC 18 February 2004 Directors' Interests I give below details of changes in directors' interests in the Ordinary Shares of GlaxoSmithKline plc. 17 February 2004 Abacus (GSK) Trustees Limited, as trustee of the GlaxoSmithKline Employee Trust, ("GSK Trust"), converted 190,282 Ordinary Shares in the Company to 95,141 ADSs which were subsequently transferred to participants in the GlaxoSmithKline Performance Share Plan. 17 February 2004 Abacus (GSK) Trustees Limited, as trustee of the GSK Trust, transferred 277,348 Ordinary Shares in the Company to participants in the GlaxoSmithKline Performance Share Plan. 17 February 2004 Abacus Corporate Trustee Limited, as trustee of the GlaxoSmithKline US Trust, ("GSK US Trust"), transferred 3,913 ADSs in the Company to participants in the GlaxoSmithKline Performance Share Plan. The Company was advised of these transactions on 18 February 2004. The GSK Trust is a discretionary trust of which all employees or former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. Three of the Company's directors, Dr J-P Garnier, Dr T Yamada and Mr J D Coombe are therefore interested in the shares held in the GSK Trust from time to time in the same way as other employees or former employees of GlaxoSmithKline plc and its subsidiaries. The GSK US Trust is a grantor trust of which all employees or former employees of SmithKline Beecham Corporation and its subsidiaries are potential beneficiaries. Two of the Company's directors, Dr J-P Garnier and Dr T Yamada are therefore interested in the shares held in the GSK US Trust from time to time in the same way as other employees or former employees of SmithKline Beecham Corporation and its subsidiaries. S M Bicknell Company Secretary 18 February 2004 This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100